Status:
COMPLETED
Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris
Lead Sponsor:
Institut de Recherches Internationales Servier
Conditions:
Angina Pectoris
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
To test whether ivabradine when given in combination with atenolol is able to improve the exercise tolerance of patients with stable angina pectoris
Eligibility Criteria
Inclusion
- Chronic stable angina pectoris
- Documented coronary artery disease
- Previous treatment with atenolol or other beta-blocker agent
- Exercise tolerance test positivity and stability
Exclusion
- Heart rate \< 60 bpm
- Congestive heart failure
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00202566
Start Date
June 1 2005
End Date
October 1 2007
Last Update
March 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal Heart Institute
Montreal, Quebec, Canada, H1T 1C8